Skip to main content
. 2023 Jul 22;24(14):11803. doi: 10.3390/ijms241411803

Figure 1.

Figure 1

From a sample of blood, either from patients or donors, T or NK cells are harvested and transfected with the gene encoding CAR. The resulting CAR-T/-NK cells, bearing the chimeric receptor, are administered to patients. The interaction between CAR-T/-NK cells with tumour cells will lead to lysis.